The relationship between repeat resection and overall survival in patients with glioblastoma: a time-dependent analysis

被引:40
|
作者
Goldman, Debra A. [1 ]
Hovinga, Koos [2 ,4 ]
Reiner, Anne S. [1 ]
Esquenazi, Yoshua [2 ,3 ]
Tabar, Viviane [2 ]
Panageas, Katherine S. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, 1275 York Ave, New York, NY 10021 USA
[3] Univ Texas Hlth Sci Ctr Houston, Vivian L Smith Dept Neurosurg, Houston, TX 77030 USA
[4] Slotervaart Hosp, Dept Neurosurg, Amsterdam, Netherlands
关键词
glioblastoma; proportional hazards model; repeat surgery; survival analysis; time-dependent model; oncology; RECURRENT GLIOBLASTOMA; PROGNOSTIC-FACTORS; EXTENT; IMPACT; BIAS; REOPERATION; MULTIFORME; THERAPY; SURGERY; STATES;
D O I
10.3171/2017.6.JNS17393
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
OBJECTIVE Previous studies assessed the relationship between repeat resection and overall survival ( OS) in patients with glioblastoma, but ignoring the timing of repeat resection may have led to biased conclusions. Statistical methods that take time into account are well established and applied consistently in other medical fields. The goal of this study was to illustrate the change in the effect of repeat resection on OS in patients with glioblastoma once timing of resection is incorporated. METHODS The authors conducted a retrospective study of patients initially diagnosed with glioblastoma between January 2005 and December 2014 who were treated at Memorial Sloan Kettering Cancer Center. Patients underwent at least 1 craniotomy with both pre-and postoperative MRI data available. The effect of repeat resection on OS was assessed with time-dependent extended Cox regression controlling for extent of resection, initial Karnofsky Performance Scale score, sex, age, multifocal status, eloquent status, and postoperative treatment. RESULTS Eighty-nine ( 55%) of 163 patients underwent repeat resection with a median time between resections of 7.7 months ( range 0.5-50.8 months). Median OS was 18.8 months ( 95% confidence interval [CI] 16.3-20.5 months) from initial resection. When timing of repeat resection was ignored, repeat resection was associated with a lower risk of death ( hazard ratio [HR] 0.62, 95% CI 0.43-0.90, p = 0.01); however, when timing was taken into account, repeat resection was associated with a higher risk of death ( HR 2.19, 95% CI 1.47-3.28, p < 0.001). CONCLUSIONS In this study, accounting for timing of repeat resection reversed its protective effect on OS, suggesting repeat resection may not benefit OS in all patients. These findings establish a foundation for future work by accounting for timing of repeat resection using time-dependent methods in the evaluation of repeat resection on OS. Additional recommendations include improved data capture that includes mutational data, development of algorithms for determining eligibility for repeat resection, more rigorous statistical analyses, and the assessment of additional benefits of repeat resection, such as reduction of symptom burden and enhanced quality of life.
引用
收藏
页码:1231 / 1239
页数:9
相关论文
共 50 条
  • [31] 5-Aminolevulinic acid-guided resection improves the overall survival of patients with glioblastoma-a comparative cohort study of 343 patients
    Mirza, Asfand Baig
    Christodoulides, Ioannis
    Lavrador, Jose Pedro
    Giamouriadis, Anastasios
    Vastani, Amisha
    Boardman, Timothy
    Ahmed, Razna
    Norman, Irena
    Murphy, Christopher
    Devi, Sharmila
    Vergani, Francesco
    Gullan, Richard
    Bhangoo, Ranjeev
    Ashkan, Keyoumars
    NEURO-ONCOLOGY ADVANCES, 2021, 3 (01)
  • [32] Effect of health disparities on overall survival of patients with glioblastoma
    Mandel, Jacob J.
    Youssef, Michael
    Nam, Jooyeon
    Patel, Akash J.
    Jalali, Ali
    Ludmir, Ethan B.
    Liu, Diane
    Wu, Jimin
    Armstrong, Georgina
    Huse, Jason
    Bondy, Melissa
    de Groot, John F.
    JOURNAL OF NEURO-ONCOLOGY, 2019, 142 (02) : 365 - 374
  • [33] Association Between Age and Overall Survival of Patients With Hepatocellular Carcinoma After Hepatic Resection
    Tan, Jun-Tao
    Zhao, Chang
    Peng, Ning-Fu
    Yang, Yang
    Zhong, Jian-Hong
    Yang, Tian
    Zheng, Ming-Hua
    Wang, Yan-Yan
    Gong, Wen-Feng
    Xiang, Bang-De
    Li, Le-Qun
    JOURNAL OF SURGICAL ONCOLOGY, 2016, 114 (08) : 966 - 970
  • [34] Impact of surgical timing on survival in patients with infective endocarditis: a time-dependent analysis
    Ripa, Marco
    Chiappetta, Stefania
    Castiglioni, Barbara
    Agricola, Eustachio
    Busnardo, Elena
    Carletti, Silvia
    Castiglioni, Alessandro
    De Bonis, Michele
    La Canna, Giovanni
    Oltolini, Chiara
    Pajoro, Ursola
    Pasciuta, Renee
    Tassan Din, Chiara
    Scarpellini, Paolo
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2021, 40 (06) : 1319 - 1324
  • [35] Impact of surgical timing on survival in patients with infective endocarditis: a time-dependent analysis
    Marco Ripa
    Stefania Chiappetta
    Barbara Castiglioni
    Eustachio Agricola
    Elena Busnardo
    Silvia Carletti
    Alessandro Castiglioni
    Michele De Bonis
    Giovanni La Canna
    Chiara Oltolini
    Ursola Pajoro
    Renée Pasciuta
    Chiara Tassan Din
    Paolo Scarpellini
    European Journal of Clinical Microbiology & Infectious Diseases, 2021, 40 : 1319 - 1324
  • [36] The Association Between the Extent of Glioblastoma Resection and Survival in Light of MGMT Promoter Methylation in 326 Patients With Newly Diagnosed IDH-Wildtype Glioblastoma
    Incekara, Fatih
    Smits, Marion
    van der Voort, Sebastian R.
    Dubbink, Hendrik Jan
    Atmodimedjo, Peggy N.
    Kros, Johan M.
    Vincent, Arnaud J. P. E.
    van den Bent, Martin
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [37] Clinical Risk and Overall Survival in Patients with Diabetes Mellitus, Hyperglycemia and Glioblastoma Multiforme. A Review of the Current Literature
    Montemurro, Nicola
    Perrini, Paolo
    Rapone, Biagio
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2020, 17 (22) : 1 - 18
  • [38] Overall survival in patients with glioblastoma before and after bevacizumab approval
    Johnson, Derek R.
    Omuro, Antonio M. P.
    Ravelo, Arliene
    Sommer, Nicolas
    Guerin, Annie
    Ionescu-Ittu, Raluca
    Shi, Sherry
    Macalalad, Alex
    Uhm, Joon H.
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (05) : 813 - 820
  • [39] Comorbid Medical Conditions as Predictors of Overall Survival in Glioblastoma Patients
    Carr, Matthew T.
    Hochheimer, Camille J.
    Rock, Andrew K.
    Dincer, Alper
    Ravindra, Lakshmi
    Zhang, Fan Lily
    Opalak, Charles F.
    Poulos, Nora
    Sima, Adam P.
    Broaddus, William C.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [40] Comparison of Survival Outcomes Between Partial Resection and Biopsy for Primary Glioblastoma: A Propensity Score-Matched Study
    Byun, Joonho
    Kim, Young-Hoon
    Nam, Soo Jung
    Park, Ji Eun
    Cho, Young Hyun
    Kim, Ho Sung
    Hong, Seok Ho
    Kim, Jeong Hoon
    Kim, Sang Joon
    Kim, Chang Jin
    WORLD NEUROSURGERY, 2019, 121 : E858 - E866